Soretolide
Soretolide is an antiepileptic agent. Soretolide is effective in maximal electroshock-induced seizure (MES) test in rodents. Soretolide inhibits metabolism of Phenytoin. Soretolide exhibits a good pharmacokinetic character in rats model[1].
Product Specifications
CAS Number
130403-08-6
UNSPSC
12352005
Hazard Statement
H302-H315-H319
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/soretolide.html
Solubility
10 mM in DMSO
Smiles
CC1=CC(NC(C2=C(C)C=CC=C2C)=O)=NO1
Molecular Formula
C13H14N2O2
Molecular Weight
230.26
Precautions
P264-P270-P280-P302+P352-P330-P362+P364-P501
References & Citations
[1]Luszczki JJ. Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions. Pharmacol Rep. 2009 Mar-Apr;61 (2) :197-216.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040992-500 1x 500 µL
SOX10 (SOX10/992), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-V096270-250MG 250 mg
L-Valyl-L-histidyl-L-leucyl-L-threonyl-L-prolyl-L-glutamic Acid Trifluoroacetate
Sign In for Pricing
View Details 
